Cure Launches Biomedical Innovation Index

Cure (healthcare innovation ecosystem) has launched the Cure Innovation Index, a pioneering data-driven framework designed to measure the effectiveness of U.S. biomedical institutions in translating scientific discoveries into real-world healthcare solutions. This index, developed in collaboration with experts and Deerfield Management's Deerfield Intelligence, evaluates 25 indicators across Research Capabilities, Entrepreneurial Readiness, and Market Translation. It ranks 303 top U.S. biomedical institutions, including leading universities like Harvard University, Stanford University, University of Pennsylvania, Massachusetts Institute of Technology, and University of California, San Francisco, as well as institutes such as Mass General Brigham, Mayo Clinic, Scripps Research, Memorial Sloan Kettering Cancer Center, and Dana–Farber Cancer Institute. The Index also identifies 20 institutions, including Indiana University Indianapolis and New York Medical College, that 'punch above their weight' in translational success. Seema Kumar, CEO of Cure (healthcare innovation ecosystem), and Thomas Sakmar of Rockefeller University, highlighted the Index's role in redefining success in biomedical research beyond traditional metrics, aiming to accelerate progress towards cures and enhance the United States' leadership in biomedical innovation.